Skip to content

000230.KS

Ildong Holdings Co., Ltd.

KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR

KRW 6,300.00
−3.82%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue607.2B590.9B657.6B638.4B675.5B
Cost of Revenue377.7B375.7B424.8B439.6B436.4B
Gross Profit229.5B215.1B232.8B198.9B239.1B
Operating Expenses
R&D Expense27.0B35.5B55.9B108.0B119.4B
SG&A Expense66.6B69.0B71.3B168.4B200.2B
General & Admin Expense10.5B12.2B15.7B117.8B120.2B
Selling & Marketing Expense56.0B56.8B55.5B50.6B80.1B
Other Expenses109.4B98.5B108.0B2.1B17.7B
Total Operating Expenses203.0B203.0B235.2B278.4B337.4B
Cost and Expenses583.2B576.0B660.0B718.0B773.8B
Operating Income (EBIT)26.2B12.1B(2.4B)(79.6B)(98.3B)
Non-Operating
Interest Income661.5M666.5M1.1B1.4B1.7B
Interest Expense13.7B23.2B34.1B30.1B17.2B
Net Interest Income(13.1B)(22.5B)(33.0B)(28.7B)(15.5B)
Other Non-Op Income/Expense27.3B15.2B55.9B(52.5B)(74.5B)
Non-Operating Income (excl Interest)(41.1B)(38.4B)(90.1B)22.4B57.3B
EBT (Pre-Tax Income)53.3B30.3B53.5B(132.1B)(173.0B)
Income Tax Expense10.4B11.1B(2.1B)(13.3B)21.6B
Bottom Line
Net Income21.7B10.9B63.0B(59.6B)(102.4B)
Earnings from Cont. Ops42.9B19.3B55.6B(118.8B)(194.5B)
Earnings from Discont. Ops412.1M2.3B535.5K
Bottom Line Net Income21.7B10.9B63.0B(59.6B)(102.4B)
Per Share
Basic EPS₩2,653₩967₩5,583(₩5,277)(₩9,064)
Diluted EPS₩2,653₩967₩5,063(₩5,277)(₩9,064)
Revenue Per Share₩7,103₩51,204₩58,233₩56,540₩59,825
Shares
Basic Shares Outstanding85.5M11.5M11.3M11.3M11.3M
Diluted Shares Outstanding85.5M11.5M12.9M11.3M11.3M
Profitability Metrics
EBITDA53.2B41.5B124.4B(64.0B)(116.3B)
D&A28.1B29.3B36.5B37.9B39.4B
EBIT25.1B12.1B87.6B(102.0B)(155.7B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026